These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 6974112)

  • 21. Acquisition of a limited lifespan by differentiating cells derived from PC13 embryonal carcinoma cells.
    Rayner MJ; Pulsford JA
    J Cell Sci; 1984 Dec; 72():227-40. PubMed ID: 6335886
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The bHLH protein MyoR inhibits the differentiation of early embryonic endoderm.
    Yu L; Sangster N; Perez A; McCormick PJ
    Differentiation; 2004 Sep; 72(7):341-7. PubMed ID: 15554945
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cultured stem-cells from human testicular teratomas: the nature of human embryonal carcinoma, and its comparison with two types of yolk-sac carcinoma.
    Pera MF; Blasco Lafita MJ; Mills J
    Int J Cancer; 1987 Sep; 40(3):334-43. PubMed ID: 2442105
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hepatocytic transcription factor expression in human embryonal carcinoma and yolk sac carcinoma cell lines: expression of HNF-3 alpha in models of early endodermal cell differentiation.
    Roach S; Schmid W; Pera MF
    Exp Cell Res; 1994 Nov; 215(1):189-98. PubMed ID: 7957668
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Embryonal carcinoma cells differentiate into parietal endoderm via an intermediate stage corresponding to primitive endoderm.
    Damjanov I; Zhu ZM; Andrews PW; Fenderson BA
    In Vivo; 1994; 8(6):967-73. PubMed ID: 7772748
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Changes in S1P1 and S1P2 expression during embryonal development and primitive endoderm differentiation of F9 cells.
    Hiraga Y; Kihara A; Sano T; Igarashi Y
    Biochem Biophys Res Commun; 2006 Jun; 344(3):852-8. PubMed ID: 16631609
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A new differentiated cell line (Dif 5) derived by retinoic acid treatment of F9 teratocarcinoma cells capable of extracellular matrix production and growth in the absence of serum.
    Nagarajan L; Jetten AM; Anderson WB
    Exp Cell Res; 1983 Sep; 147(2):315-27. PubMed ID: 6193979
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Differentiation-dependent production of a platelet-derived growth factor-like mitoattractant by endoderm cells derived from embryonal carcinoma cells.
    Grotendorst GR; Harvey AK; Nagarajan L; Anderson WB; Gatewood E
    J Cell Physiol; 1988 Mar; 134(3):437-44. PubMed ID: 2832423
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Identification and immunoprecipitation of cytoskeletal proteins from murine extra-embryonic endodermal cells.
    Oshima RG
    J Biol Chem; 1981 Aug; 256(15):8124-33. PubMed ID: 7263644
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Isolation and characterization of a multipotent clone of human embryonal carcinoma cells.
    Pera MF; Cooper S; Mills J; Parrington JM
    Differentiation; 1989 Oct; 42(1):10-23. PubMed ID: 2559868
    [TBL] [Abstract][Full Text] [Related]  

  • 31. H1 histone and nucleosome repeat length alterations associated with the in vitro differentiation of murine embryonal carcinoma cells to extra-embryonic endoderm.
    Oshima R; Curiel D; Linney E
    J Supramol Struct; 1980; 14(1):85-96. PubMed ID: 6261041
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Roles of the Nanog protein in murine F9 embryonal carcinoma cells and their endoderm-differentiated counterparts.
    Chen Y; Du Z; Yao Z
    Cell Res; 2006 Jul; 16(7):641-50. PubMed ID: 16773043
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The amount of a specific cellular protein (p53) is a correlate of differentiation in embryonal carcinoma cells.
    Chandrasekaran K; Mora PT; Nagarajan L; Anderson WB
    J Cell Physiol; 1982 Oct; 113(1):134-40. PubMed ID: 6290508
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Immature endodermal teratoma of the ovary: embryologic correlations and immunohistochemistry.
    Nogales FF; Ruiz Avila I; Concha A; del Moral E
    Hum Pathol; 1993 Apr; 24(4):364-70. PubMed ID: 8491476
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Neuron-like derivatives of cultured F9 embryonal carcinoma cells express characteristics of parietal endoderm cells.
    Tienari J; Virtanen I; Soinila S; Lehtonen E
    Dev Biol; 1987 Oct; 123(2):566-73. PubMed ID: 2820818
    [TBL] [Abstract][Full Text] [Related]  

  • 36. RXRalpha-null F9 embryonal carcinoma cells are resistant to the differentiation, anti-proliferative and apoptotic effects of retinoids.
    Clifford J; Chiba H; Sobieszczuk D; Metzger D; Chambon P
    EMBO J; 1996 Aug; 15(16):4142-55. PubMed ID: 8861943
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [A strategy for immortalizing lines committed to endoderm, neuroectoderm or mesoderm from mouse teratocarcinoma].
    Buc-Caron MH; Launay JM; Marie PJ; Kellermann O
    Reprod Nutr Dev; 1990; 30(3):309-16. PubMed ID: 2168713
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Analysis of cell-differentiation lineage in human teratomas using new monoclonal antibodies to cytostructural antigens of embryonal carcinoma cells.
    Pera MF; Blasco-Lafita MJ; Cooper S; Mason M; Mills J; Monaghan P
    Differentiation; 1988 Dec; 39(2):139-49. PubMed ID: 3243384
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Fibroblast growth factor-mediated growth regulation and receptor expression in embryonal carcinoma and embryonic stem cells and human germ cell tumours.
    Mummery CL; van Rooyen M; Bracke M; van den Eijnden-van Raaij J; van Zoelen EJ; Alitalo K
    Biochem Biophys Res Commun; 1993 Feb; 191(1):188-95. PubMed ID: 7680555
    [TBL] [Abstract][Full Text] [Related]  

  • 40. F9 embryonal carcinoma cells can differentiate into endoderm-like cells.
    Sherman MI; Miller RA
    Dev Biol; 1978 Mar; 63(1):27-34. PubMed ID: 631430
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.